Page last updated: 2024-10-26

ebselen and Cardiac Toxicity

ebselen has been researched along with Cardiac Toxicity in 1 studies

ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.

Research Excerpts

ExcerptRelevanceReference
"Arenobufagin is a naturally occurring bufadienolide showing promising antitumor activity accompanied however with apparent cardiac toxicity."7.88Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin. ( Chang, YQ; Chen, WM; Hou, W; Huang, ZX; Lin, H; Lin, J; Peng, QL; Sun, PH; Wang, LH; Xu, HG; Yao, Z; Zhang, DM, 2018)
"Arenobufagin is a naturally occurring bufadienolide showing promising antitumor activity accompanied however with apparent cardiac toxicity."3.88Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin. ( Chang, YQ; Chen, WM; Hou, W; Huang, ZX; Lin, H; Lin, J; Peng, QL; Sun, PH; Wang, LH; Xu, HG; Yao, Z; Zhang, DM, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hou, W1
Huang, ZX1
Xu, HG1
Lin, J1
Zhang, DM1
Peng, QL1
Lin, H1
Chang, YQ1
Wang, LH1
Yao, Z1
Sun, PH1
Chen, WM1

Other Studies

1 other study available for ebselen and Cardiac Toxicity

ArticleYear
Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin.
    Bioorganic & medicinal chemistry letters, 2018, 11-01, Volume: 28, Issue:20

    Topics: Antineoplastic Agents; Bufanolides; Cardiotoxicity; Cell Line, Tumor; Drug Design; Free Radical Scav

2018